Review




Structured Review

Merck & Co p38 a-specific mapk inhibition
P38 A Specific Mapk Inhibition, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38+a-specific+mapk+inhibition/p38map+sb203580/pm16275622-39-12-18
Average 90 stars, based on 1 article reviews
p38 a-specific mapk inhibition - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model.
Article Snippet: Features of acute lung injury include neutrophil influx and increased vascular permeability with resultant pulmonary edema.. Inhibition of p38 mitogen-activated protein kinase (MAPK) in in vivo models of endotoxin-induced inflammation results in reduction of organ injury as well as symptomatic relief.. In this study, mice received an oral dose (100 mg/kg) of the p38 MAPK inhibitor, SB203580, followed by intratracheal instillation of an agent of complement origin, C5a des arg, at a concentration (10 Ag) that induced acute lung injury.



Similar Products

90
Merck & Co p38 a-specific mapk inhibition
P38 A Specific Mapk Inhibition, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38+a-specific+mapk+inhibition/p38map+sb203580/pm16275622-39-12-18
Average 90 stars, based on 1 article reviews
p38 a-specific mapk inhibition - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore sb203580 specific inhibiter of p38 mapk
Sb203580 Specific Inhibiter Of P38 Mapk, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38+a-specific+mapk+inhibition/sb203580/pm14770043-37-0-9
Average 90 stars, based on 1 article reviews
sb203580 specific inhibiter of p38 mapk - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore sb203580 (a specific p38 inhibitor that does not inhibit the activity of other mapk, turchi et al ., 2000 )
Aspirin induces <t>p38</t> activation in B16 cells. B16 cells (at 4 × 105 well−1) were seeded in six-well plates and allowed to adhere overnight. The cells were then treated with or without (0) aspirin at 3 mMfor the indicated periods of time. For analysis of phospho-p38 (indicating p38 activation) levels, whole-cell lysates were prepared (Samet et al., 1998) and proteins were separated by SDS-PAGE, followed by immunoblotting using specific antibodies against phospho-p38. Antigen&–antibody complexes were stained with HRP-conjugated antibody and enhanced chemiluminescence reagent, and exposed to ECL film. Immunoblot images were digitized and the optical densities of specific antigen-antibody complexes were quantified. A typical experiment is shown, representing two experiments with similar results.
Sb203580 (A Specific P38 Inhibitor That Does Not Inhibit The Activity Of Other Mapk, Turchi Et Al ., 2000 ), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p38+a-specific+mapk+inhibition/sb203580/pmc01573760-43-0-39
Average 90 stars, based on 1 article reviews
sb203580 (a specific p38 inhibitor that does not inhibit the activity of other mapk, turchi et al ., 2000 ) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Aspirin induces p38 activation in B16 cells. B16 cells (at 4 × 105 well−1) were seeded in six-well plates and allowed to adhere overnight. The cells were then treated with or without (0) aspirin at 3 mMfor the indicated periods of time. For analysis of phospho-p38 (indicating p38 activation) levels, whole-cell lysates were prepared (Samet et al., 1998) and proteins were separated by SDS-PAGE, followed by immunoblotting using specific antibodies against phospho-p38. Antigen&–antibody complexes were stained with HRP-conjugated antibody and enhanced chemiluminescence reagent, and exposed to ECL film. Immunoblot images were digitized and the optical densities of specific antigen-antibody complexes were quantified. A typical experiment is shown, representing two experiments with similar results.

Journal:

Article Title: Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation

doi: 10.1038/sj.bjp.0705163

Figure Lengend Snippet: Aspirin induces p38 activation in B16 cells. B16 cells (at 4 × 105 well−1) were seeded in six-well plates and allowed to adhere overnight. The cells were then treated with or without (0) aspirin at 3 mMfor the indicated periods of time. For analysis of phospho-p38 (indicating p38 activation) levels, whole-cell lysates were prepared (Samet et al., 1998) and proteins were separated by SDS-PAGE, followed by immunoblotting using specific antibodies against phospho-p38. Antigen&–antibody complexes were stained with HRP-conjugated antibody and enhanced chemiluminescence reagent, and exposed to ECL film. Immunoblot images were digitized and the optical densities of specific antigen-antibody complexes were quantified. A typical experiment is shown, representing two experiments with similar results.

Article Snippet: SB203580 (a specific p38 inhibitor that does not inhibit the activity of other MAPK, Turchi et al ., 2000 ) and SB202190 (an agent that inhibits both JNK and p38, Turchi et al ., 2000 ) were purchased from Calbiochem (La Jolla, CA, U.S.A.).

Techniques: Activation Assay, SDS Page, Western Blot, Staining

The JNK and p38 inhibitor SB202190 decreases aspirin-induced suppression of B16 cellular proliferation. B16 cells (at 4 × 103 well−1) were seeded in 96-well plates and allowed to adhere overnight. Aspirin at 3 mMwas added for 1 day. SB202190 was added at the indicated concentrations, 30 min before the addition of aspirin, and was removed 2.5 h afterwards. Optical density representing viable cells was determined by the CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay. Inhibition of proliferation is calculated as percentage of control cultures that were not treated with aspirin, mean±s.d. The effect of SB202190 (in comparison with None=only aspirin) was statistically significant at *P<0.05, **P<0.005, ***P<0.0005; n=3.

Journal:

Article Title: Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation

doi: 10.1038/sj.bjp.0705163

Figure Lengend Snippet: The JNK and p38 inhibitor SB202190 decreases aspirin-induced suppression of B16 cellular proliferation. B16 cells (at 4 × 103 well−1) were seeded in 96-well plates and allowed to adhere overnight. Aspirin at 3 mMwas added for 1 day. SB202190 was added at the indicated concentrations, 30 min before the addition of aspirin, and was removed 2.5 h afterwards. Optical density representing viable cells was determined by the CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay. Inhibition of proliferation is calculated as percentage of control cultures that were not treated with aspirin, mean±s.d. The effect of SB202190 (in comparison with None=only aspirin) was statistically significant at *P<0.05, **P<0.005, ***P<0.0005; n=3.

Article Snippet: SB203580 (a specific p38 inhibitor that does not inhibit the activity of other MAPK, Turchi et al ., 2000 ) and SB202190 (an agent that inhibits both JNK and p38, Turchi et al ., 2000 ) were purchased from Calbiochem (La Jolla, CA, U.S.A.).

Techniques: Proliferation Assay, Inhibition